These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6101699)

  • 1. Potentiation of warfarin action by sulphinpyrazone.
    Bailey RR; Reddy J
    Lancet; 1980 Feb; 1(8162):254. PubMed ID: 6101699
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves.
    Girolami A; Fabris F; Casonato A; Randi ML
    Clin Lab Haematol; 1982; 4(1):23-6. PubMed ID: 7067372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphinpyrazone and warfarin: a probable drug interaction.
    Gallus A; Birkett D
    Lancet; 1980 Mar; 1(8167):535-6. PubMed ID: 6102248
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelets, cardiac valves and sulphinpyrazone.
    Loeliger EA
    Thromb Haemost; 1982 Apr; 47(2):189. PubMed ID: 7101242
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):321-6. PubMed ID: 7106168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of sulphinpyrazone.
    Wallis RB
    Thromb Res Suppl; 1983; 4():31-8. PubMed ID: 6415857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.
    Huijgens PC; van den Berg CA; Imandt LM; Langenhuijsen MM
    Thromb Res; 1981 Nov; 24(3):267-70. PubMed ID: 7336383
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.
    Birkett DJ; Miners JO; Attwood J
    Br J Clin Pharmacol; 1983 May; 15(5):567-9. PubMed ID: 6860533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The effect of sulphinpyrazone (Anturan) on immunologically derived thrombocytopenia and on platelet survival.
    White AM; Butler KD
    Thromb Diath Haemorrh; 1975 Nov; 34(2):553-4. PubMed ID: 128152
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulphinpyrazone, aspirin, and uric acid.
    Newland HR
    Lancet; 1980 Apr; 1(8171):770. PubMed ID: 6103187
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: The effect of sulphinpyrazone, sodium aspirin and oxprenolol on the formation of arterial platelet thrombi.
    Lewis GP; Westwick J
    Br J Pharmacol; 1975 Oct; 55(2):255P-256P. PubMed ID: 1201396
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo.
    Pay GF; Wallis RB; Zelaschi D
    Haemostasis; 1981; 10(3):165-75. PubMed ID: 7262645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
    Nunn B; James FJ
    Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigs.
    Butler KD; Pay GF; Roberts JM; White AM
    Thromb Res; 1979; 15(3-4):319-40. PubMed ID: 158844
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic sulphinpyrazone-warfarin interaction.
    Nenci GG; Agnelli G; Berrettini M
    Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1361-2. PubMed ID: 6786498
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of sulphinpyrazone with warfarin.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):327-31. PubMed ID: 7106169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Forssman-induced bronchospasm and their inhibition.
    Butler KD; Smith JR
    Br J Pharmacol; 1981 May; 73(1):25-32. PubMed ID: 7284697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in man.
    Maguire ED; Pay GF; Turney J; Wallis RB; Weston MJ; White AM; Williams LC; Woods HF
    Haemostasis; 1981; 10(3):153-64. PubMed ID: 7262644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
    He M; Kunze KL; Trager WF
    Drug Metab Dispos; 1995 Jun; 23(6):659-63. PubMed ID: 7587949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.